Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

284
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
284
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

164
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
164
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

140
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
140
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

244
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
244
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

131
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
131
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

326
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
326

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

The Use of Quantitative Thermography to Assess the Anti-inflammatory Dose Range for Fenclofenac.

Proceedings of the Royal Society of Medicine·2010
Same author

Intracellular calcium signalling patterns reflect the differentiation status of human T cells.

Clinical and experimental immunology·2008
Same author

Impaired endothelial function in systemic lupus erythematosus.

Lupus·2007
Same author

Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

Annals of the rheumatic diseases·2005
Same author

Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects.

Current opinion in rheumatology·2004
Same journal

Giving life, giving death: ethical problems of high-technology medicine.

Acta medica Scandinavica. Supplementum·1988
Same journal

Potential importance of the muscles for the development of insulin resistance in obesity.

Acta medica Scandinavica. Supplementum·1988
Same journal

Potential role of adipose tissue for the development of insulin resistance in obesity.

Acta medica Scandinavica. Supplementum·1988
Same journal

Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: window with a view.

Acta medica Scandinavica. Supplementum·1988
Same journal

Physical training and changes in regional adipose tissue distribution.

Acta medica Scandinavica. Supplementum·1988
Same journal

Hormonal abnormalities in obesity.

Acta medica Scandinavica. Supplementum·1988
See all related articles

Related Experiment Video

Updated: Jan 2, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

1.0K

Vasculitis--clinical aspects and therapy

P A Bacon

    Acta Medica Scandinavica. Supplementum
    |January 1, 1987
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    7.5K
    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
    09:33

    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

    Published on: February 7, 2015

    16.7K

    Related Experiment Videos

    Last Updated: Jan 2, 2026

    Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
    05:44

    Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

    Published on: May 24, 2024

    1.0K
    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    7.5K
    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
    09:33

    A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

    Published on: February 7, 2015

    16.7K